Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by The300on Mar 31, 2011 9:55am

206 Views

Post# 18366258

Great Press Release

I particularly like the intersection of 7.23 g/t gold and 65.12 g/t silver over 11.7 m. Very nice interval.

There are definitely alot more precious metal credits at Cold-Lost than we initially thought, so nice bonus.

I'm sure that Hudbay has taken note of this as well.

There may be a buying opportunity at this point as the shareprice is still showing weakness this AM. I'm guessing it is because most have not picked up on this news.

I think we're one step closer to getting the answer we are hoping for from Hudbay.

Regards,

The 300

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages